| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| LIGHT | HOT LIT-M5243 | Mouse LIGHT / TNFSF14 Protein, His Tag, active trimer (MALS verified) | Mouse | HEK293 | MALSSDS-PAGE | $380.00 100ug | |||
| LIGHT | HOT LIT-H5269 | Human LIGHT / TNFSF14 Protein, Fc Tag, active trimer, low endotoxin (MALS verified) | Human | HEK293 | MALSSDS-PAGE | $360.00 100ug | |||
| LIGHT | HOT LIT-C5244 | Cynomolgus LIGHT / TNFSF14 Protein, His Tag, active trimer, low endotoxin (MALS verified) | Cynomolgus | HEK293 | MALSSDS-PAGE | $380.00 100ug | |||
| LIGHT | HOT LIT-H5242 | Human LIGHT / TNFSF14 Protein, His Tag, active trimer, low endotoxin (MALS verified) | Human | HEK293 | MALSSDS-PAGE | $435.00 100ug | |||
| LIGHT | Human LIGHT / TNFSF14 Protein, His Tag, Ultra Low Endotoxin (MALS verified) | Human | HEK293 | MALSSDS-PAGE | $380.00 100ug | ||||
| LIGHT | Human LIGHT / TNFSF14 Protein, Mouse IgG2a Fc Tag, low endotoxin | Human | HEK293 | ![]() | SDS-PAGE | $360.00 100ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Quisovalimab | CERC-002; AEVI-002; MDGN-002; SAR-252067; AVTX-002 | Phase 2 Clinical | Kyowa Hakko Kirin Co Ltd, La Jolla Pharmaceutical Company | Acute Lung Injury; Asthma; Colitis, Ulcerative; Coronavirus Disease 2019 (COVID-19); Crohn Disease; Respiratory Distress Syndrome, Adult | Details |
